We are live on ! Find out more
ACM

Atika Capital Management Portfolio holdings

AUM $796M
1-Year Est. Return 167.57%
This Fund
S&P 500
This Quarter Est. Return
+25.91%
1 Year Est. Return
+167.57%
3 Year Est. Return
+553.47%
5 Year Est. Return
+1,283.26%
10 Year Est. Return
+44,203.78%
AUM
$245M
AUM Growth
+$11.4M
Cap. Flow
-$16.4M
Cap. Flow %
-6.72%
Top 10 Hldgs %
38.84%
Holding
86
New
26
Increased
18
Reduced
21
Closed
20

Sector Composition

Rank Sector Weight
1 Healthcare 32.27%
2 Consumer Discretionary 14.35%
3 Technology 12.94%
4 Communication Services 8.75%
5 Industrials 3.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DPZ icon
51
Domino's
DPZ
$12.1B
$1.97M 0.81%
13,000
-1,000
-7% -$146K
ELF icon
52
e.l.f. Beauty
ELF
$4.87B
$1.97M 0.8%
+70,000
New +$1.83M
ELLI
53
DELISTED
Ellie Mae Inc
ELLI
$1.9M 0.77%
+18,000
New +$1.74M
LLY icon
54
CALL
Eli Lilly
LLY
$1,000B
$1.85M 0.75%
23,000
-1,000
-4% -$80K
SYNH
55
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
$1.6M 0.66%
+36,000
New +$1.56M
ALGN icon
56
Align Technology
ALGN
$12.4B
$1.59M 0.65%
+17,000
New +$1.54M
ALNY icon
57
Alnylam Pharmaceuticals
ALNY
$29.5B
$1.49M 0.61%
22,000
+8,000
+57% +$564K
TLND
58
DELISTED
Talend S.A. American Depositary Shares
TLND
$1.39M 0.57%
+53,000
New +$1.41M
ISEE
59
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$1.27M 0.52%
27,500
-1,500
-5% -$84.6K
EGHT icon
60
8x8 Inc
EGHT
$292M
$1.26M 0.52%
+82,000
New +$1.17M
SIOX
61
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$1.04M 0.42%
+9,250
New +$1.11M
TCOM icon
62
Trip.com Group
TCOM
$29.8B
$885K 0.36%
19,000
-38,000
-67% -$1.69M
ARRY
63
DELISTED
Array Biopharma Inc
ARRY
$857K 0.35%
+127,000
New +$491K
NTNX icon
64
Nutanix
NTNX
$16.5B
$777K 0.32%
+21,000
New +$777K
EXEL icon
65
Exelixis
EXEL
$13.8B
$704K 0.29%
+55,000
New +$595K
ACAD icon
66
CALL
Acadia Pharmaceuticals
ACAD
$4.39B
$327K 0.13%
10,300
AVNS
67
DELISTED
Avanos Medical
AVNS
-65,000
Closed -$2.11M
BSX icon
68
Boston Scientific
BSX
$72B
-64,000
Closed -$1.5M
EPAM icon
69
EPAM Systems
EPAM
$5.6B
-32,000
Closed -$2.06M
EXP icon
70
Eagle Materials
EXP
$6.59B
-32,500
Closed -$2.51M
FIVE icon
71
Five Below
FIVE
$12B
-105,000
Closed -$4.87M
HUM icon
72
Humana
HUM
$45B
-7,000
Closed -$1.26M
ORLY icon
73
O'Reilly Automotive
ORLY
$73.3B
-183,000
Closed -$3.31M
SKX
74
DELISTED
Skechers
SKX
-32,000
Closed -$951K
SPY icon
75
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$806B
-180,000
Closed -$37.7M

Similar funds

Atika Capital Management's Q3 2016 Portfolio in Review

As of Q3 2016, Atika Capital Management held 86 positions worth $245M, up 4.9% from $233M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Atika Capital Management withdrew a net $16.4M in Q3 2016, closing 20 positions and reducing 21 holdings. Its most notable exit was Six Flags Entertainment Corp., an estimated $9.62M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, Atika Capital Management opened a new position in Dick's Sporting Goods worth $4.08M.

  • Atika Capital Management's largest Q3 2016 buy was Dick's Sporting Goods: 72,000 shares worth $4.08M.
  • Atika Capital Management added most to Autodesk in Q3 2016, an estimated $4.32M increase.
  • Atika Capital Management's biggest Q3 2016 reduction was RAPTOR PHARMACEUTICAL CORP COM STK (DE), cutting an estimated $7.54M.
  • Atika Capital Management fully exited Six Flags Entertainment Corp. in Q3 2016, selling an estimated $9.62M.
  • Atika Capital Management's ten largest holdings make up 39% of its $245M portfolio in Q3 2016.
  • Atika Capital Management opened 26 new positions and closed 20 in Q3 2016.
  • Atika Capital Management's portfolio value rose 4.9% quarter-over-quarter to $245M.

Based on Atika Capital Management's 13F filing for Q3 2016, filed 14 Nov 2016.